Penumbra Inc at Bank of America Healthcare Conference Transcript
Thanks for coming to one of the last presentations of the day. For medtech, we welcome to have Penumbra, Adam Elsesser, CEO. So glad to be here. Thank you.
Great.
Questions & Answers
So I guess just before we get into like the Q1 and all this stuff, given some of the focus on competition and stuff, I just love to like level-set where you think we are in like the different markets you're in, like in terms of TAM and penetration, if you look at both stroke, arterial and venous just kind of take the 3 down and kind of see where we are today.
Yes. So from a penetration standpoint, where stroke is at about 25 -- let's use U.S. numbers just to be easier. We're about 25% penetrated. That stalled -- that went
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
